Researchers have shown that CHB infection of the human liver and HBV-related liver cancer is linked with high expression of glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting enzyme of the pentose phosphate pathway, as well as increased Nrf2 transcription factor activity. Here, G6PD is linked to liver cancer.